Beta Drugs
Beta Drugs Share Price Chart
Beta Drugs last traded at ₹1,837.20 (2026-10-13). Over the past month the stock moved -11.9%, three months the stock moved +31.2%, year the stock moved -0.0%. Its closing range over 52 weeks is ₹1,051.60 – ₹2,550.70, with the latest close 28.0% below the high.
Closing prices up to 2026-10-13.
About Beta Drugs
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.[1]
Market Position The company is ranked among the top 10 oncology companies, and many of its key products are ranked among the top 5 in their respective categories. [1]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Beta Drugs reported sales of ₹126.00 crore (+26.0%) and net profit of ₹16.00 crore (+33.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 126.00 | 27.00 | 22.00 | 16.00 | 15.16 |
| Mar 2026 | 94.00 | 18.00 | 19.00 | 9.00 | 8.93 |
| Dec 2025 | 87.00 | 17.00 | 19.00 | 9.00 | 8.40 |
| Sep 2025 | 103.00 | 21.00 | 21.00 | 12.00 | 12.11 |
| Jun 2025 | 100.00 | 20.00 | 20.00 | 12.00 | 11.59 |
| Mar 2025 | 94.00 | 17.00 | 18.00 | 9.00 | 8.95 |
| Dec 2024 | 88.00 | 18.00 | 21.00 | 9.00 | 8.86 |
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales growth | -1.1% | +0.0% | +26.0% |
| Operating profit growth | -5.6% | +5.9% | +35.0% |
| Net profit growth | +0.0% | +0.0% | +33.3% |
| EPS growth | -5.2% | -0.2% | +30.8% |
| OPM % | 19.0% | 19.0% | 22.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Beta Drugs reported sales of ₹385.00 crore (+6.4%) and net profit of ₹41.00 crore (-2.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 385.00 | 76.00 | 20.00 | 41.00 | 40.92 |
| Mar 2025 | 362.00 | 75.00 | 21.00 | 42.00 | 42.02 |
| Mar 2024 | 296.00 | 60.00 | 20.00 | 36.00 | 36.08 |
| Mar 2023 | 227.00 | 53.00 | 23.00 | 31.00 | 30.42 |
| Mar 2022 | 184.00 | 43.00 | 23.00 | 25.00 | 24.58 |
| Mar 2021 | 116.00 | 25.00 | 21.00 | 12.00 | 11.60 |
| Mar 2020 | 91.00 | 18.00 | 20.00 | 9.00 | 9.33 |
| Mar 2019 | 66.00 | 12.00 | 18.00 | 8.00 | 8.84 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +29.4% | +37.9% | +27.5% | +58.6% | +23.4% | +30.4% | +22.3% | +6.4% |
| Operating profit growth | +33.3% | +50.0% | +38.9% | +72.0% | +23.3% | +13.2% | +25.0% | +1.3% |
| Net profit growth | +14.3% | +12.5% | +33.3% | +108.3% | +24.0% | +16.1% | +16.7% | -2.4% |
| EPS growth | +19.0% | +5.5% | +24.3% | +111.9% | +23.8% | +18.6% | +16.5% | -2.6% |
| OPM % | 18.0% | 20.0% | 21.0% | 23.0% | 23.0% | 20.0% | 21.0% | 20.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Beta Drugs.
Get Free AI Stock Analysis FREE →Latest News
-
Debt Other Latest Corporate Announcements, ScripcodeLatest Company News - beta.bseindia.com
-
Stock Beta explained: What risk and return mean for individual shares - Business Standard
-
Stock Beta explained: What risk and return mean for individual shares - Business Standard
-
Debt Other Latest Corporate Announcements, ScripcodeLatest Company News - beta.bseindia.com
-
Carborundum Universal Ltd Latest Corporate Announcements, CarborunivLatest Company News - beta.bseindia.com
-
Sera Investments Finance India Ltd Latest Corporate Announcements, SeraLatest Company News - beta.bseindia.com
-
Rossell Techsys Ltd Latest Corporate Announcements, RosstechLatest Company News - beta.bseindia.com
-
Austin Engineering Company Ltd Latest Corporate Announcements, AustengLatest Company News - beta.bseindia.com
-
Royal India Corporation Ltd Latest Corporate Announcements, RoyalindLatest Company News - beta.bseindia.com
-
Debt Other Latest Corporate Announcements, ScripcodeLatest Company News - beta.bseindia.com
Frequently Asked Questions
What is Beta Drugs's current stock price?
Beta Drugs shares were last quoted at ₹1,837.20 (-5.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Beta Drugs?
Beta Drugs has a price-to-earnings (P/E) ratio of 51.04 and a price-to-book (P/B) ratio of 8.87. The industry P/E is 53.33.
What is the 52-week high and low of Beta Drugs?
The 52-week high of Beta Drugs is ₹2,807.90 and the 52-week low is ₹990.10.
What is the market cap of Beta Drugs?
The market capitalisation of Beta Drugs is about ₹2,326.59 crore.
How did Beta Drugs perform in its latest quarterly results?
In the latest quarter (Jun 2026), Beta Drugs reported sales of ₹126.00 crore (+26.0%) and net profit of ₹16.00 crore (+33.3%), compared with the same quarter last year.
Is Beta Drugs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Beta Drugs has a 3-year ROE of 23.00%, 3-year profit growth of 11.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Beta Drugs?
Promoters hold about 59.10% of Beta Drugs.
Which sector does Beta Drugs belong to?
Beta Drugs belongs to the Pharmaceuticals & Drugs sector.